CA-15.3, TPA and MCA as markers for breast cancer
- 1 January 1990
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 26 (5) , 577-580
- https://doi.org/10.1016/0277-5379(90)90081-4
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Diagnostic value of mucin-like carcinoma-associated antigen (MCA) in breast cancerEuropean Journal of Cancer and Clinical Oncology, 1989
- A mucinous-like carcinoma-associated antigen (MCA) in the tissue and blood of patients with primary breast cancerCancer, 1989
- Follow-up of metastatic breast cancer patients with a mucin-like carcinoma-associated antigen: comparison to CA 15.3 and carcinoembryonic antigenCancer Letters, 1988
- Comparison of mammary serum antigen (MSA) with β2-microglobulin (β2M) and carcinoembryonic antigen (CEA) assays in patients with breast cancerEuropean Journal of Cancer and Clinical Oncology, 1988
- Application of mammary serum antigen assay in the management of breast cancer: A preliminary reportBritish Journal of Surgery, 1988
- Correlation of serum levels of CA‐549 to disease status in posttreatment serial samples from breast cancer patientsJournal of Clinical Laboratory Analysis, 1988
- Comparison of mammary serum antigen (MSA) and CA15-3 levels in the serum of patients with breast cancerBritish Journal of Cancer, 1987
- Value of CA 15:3 in the follow-up of breast cancer patientsBritish Journal of Cancer, 1987
- Tumor markers: Value and limitations in the management of cancer patientsCancer Treatment Reviews, 1985
- Prognostic significance of CEA in breast cancer: a statistical studyEuropean Journal of Cancer and Clinical Oncology, 1981